HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $49,249 | -9.7% | 32,615 | +49.4% | 0.00% | – |
| Q4 2022 | $54,560 | -40.7% | 21,824 | 0.0% | 0.00% | – |
| Q3 2022 | $92,000 | +21.1% | 21,824 | -19.9% | 0.00% | – |
| Q2 2022 | $76,000 | -20.8% | 27,245 | +158.8% | 0.00% | – |
| Q4 2021 | $96,000 | -11.9% | 10,527 | +2.9% | 0.00% | – |
| Q3 2021 | $109,000 | -96.4% | 10,233 | -89.3% | 0.00% | -100.0% |
| Q3 2018 | $3,039,000 | -28.6% | 96,000 | -12.3% | 0.02% | -62.1% |
| Q2 2018 | $4,254,000 | +43.5% | 109,500 | +2.0% | 0.06% | +48.7% |
| Q1 2018 | $2,964,000 | -9.3% | 107,400 | -40.5% | 0.04% | -11.4% |
| Q4 2017 | $3,269,000 | +155.6% | 180,600 | +95.5% | 0.04% | +100.0% |
| Q2 2017 | $1,279,000 | +23.6% | 92,361 | +33.9% | 0.02% | +15.8% |
| Q1 2017 | $1,035,000 | – | 69,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |